Browse articles from EyeWorld.org related to IOLs. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
With increased experience, physicians are discovering ways to use the IC-8 Apthera IOL (Bausch + Lomb) off label. Two of these physicians discussed their experience using the lens, including ways that it can apply to patients who previously had limited options, particularly those with irregular astigmatism.
Mitchell Weikert, MD, Cataract Editor, promoted the ASCRS Live! meetings and gave an overview of the articles in the section in his introduction.
➤ Whole-eye transplant 1 year later ➤ Phase 3 trial investigating new presbyopia drop therapy begins ➤ Study reports on multi-interventional glaucoma technique ➤ Topline results from Phase 3 trial for drug for active thyroid eye disease ➤ Pilot study complete for AMD treatment ➤ ASCRS news and events
➤ ASCRS mourns death of I. Howard Fine, MD ➤ New non-diffractive monofocal and toric IOLs ➤ 36-month results from clinical trials for new glaucoma device ➤ FDA grants IND to stem cell therapy intended to treat photoreceptor diseases ➤ Company launches ophthalmology-specific contract research organization ➤ ASCRS news and events
➤ Study: ocular manifestations of Mpox ➤ ‘World’s first’ spiral IOL designed with artificial intelligence ➤ First-in-human implantation of wireless IOP sensor ➤ Final patient visit for Phase 2 wet AMD treatment trial ➤ Enrollment, dosing complete for Phase 1 AMD, DME therapy ➤ ASCRS news and events
➤ FDA approves expanded access for retinitis pigmentosa gene therapy ➤ Generic steroid receives FDA approval for inflammation ➤ AI-powered smart glasses provide visual help to patients with AMD ➤ ASCRS news and events
In this op-ed, Vance Thompson, MD, Chair of the ASCRS Business of Refractive Cataract Surgery Summit (BRiCS), discussed the opportunities that practices have with advanced-technology IOLs and how BRiCS will give practice teams the confidence they need to increase growth in these IOLs.
Two cornea and refractive specialists discussed the most common reasons an IOL exchange may be needed and the initial diagnostic steps to rule out other reasons for poor quality vision. They shared pearls for performing these cases and the importance of having a comprehensive plan of attack.
➤ 52-week Phase 3 data published for cyclosporine, 0.1% ➤ First patient enrolled in Phase 3 trial assessing new treatment for MGD ➤ Geographic atrophy treatment trial advances to highest dose ➤ New dataset added to support various areas of research and development ➤ ASCRS news and events
While there a lot of different technologies that can give patients excellent refractive results after cataract surgery, this area keeps expanding and improving. As more options become available, it increases the complexity of talking to patients. This is what the symposium Having “The Talk” focused on at the 2024 ASCRS Annual Meeting.